Putnam Investments LLC Eli Lilly & CO Transaction History

Putnam Investments LLC

$73 Billion
Q4 2023

A detailed history of Putnam Investments LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Putnam Investments LLC holds 1,510,259 shares of LLY stock, worth $1.2 Billion. This represents 1.21% of its overall portfolio holdings.

Number of Shares

1,510,259

Previous 1,628,961 7.29%

Holding current value

$1.2 Billion

Previous $875 Million 0.62%

% of portfolio

1.21%

Previous 1.37%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $62.3 Million - $73.5 Million	-118,702 Reduced 7.29%	1,510,259 $880 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $79.6 Million - $110 Million	-183,036 Reduced 10.1%	1,628,961 $875 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $911,222 - $1.22 Million	2,598 Added 0.14%	1,811,997 $850 Million
Q1 2023 May 22, 2023	BUY	$310.63 - $364.82 $6.17 Million - $7.25 Million	19,865 Added 1.11%	1,809,399 $621 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $11.7 Million - $13.7 Million	36,498 Added 2.08%	1,789,534 $655 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $134 Million - $153 Million	451,536 Added 34.69%	1,753,036 $567 Million
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $9.5 Million - $11.2 Million	34,089 Added 2.69%	1,301,500 $422 Million
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $85.1 Million - $106 Million	-362,532 Reduced 22.24%	1,267,411 $363 Million
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $90.7 Million - $113 Million	-403,443 Reduced 19.84%	1,629,943 $450 Million
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $469 Million - $577 Million	-2,115,124 Reduced 50.99%	2,033,386 $470 Million
Q2 2021 Aug 16, 2021	SELL	$180.55 - $233.54 $50.6 Million - $65.4 Million	-280,133 Reduced 6.33%	4,148,510 $952 Million
Q1 2021 May 17, 2021	SELL	$164.32 - $212.72 $23.1 Million - $29.9 Million	-140,367 Reduced 3.07%	4,428,643 $827 Million
Q4 2020 Feb 16, 2021	BUY	$130.46 - $172.63 $55.7 Million - $73.7 Million	426,791 Added 10.3%	4,569,010 $771 Million
Q3 2020 Nov 16, 2020	BUY	$146.22 - $169.13 $111 Million - $128 Million	757,407 Added 22.38%	4,142,219 $613 Million
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $175 Million - $210 Million	1,281,767 Added 60.95%	3,384,812 $556 Million
Q1 2020 May 15, 2020	SELL	$119.05 - $147.35 $4.86 Million - $6.02 Million	-40,830 Reduced 1.9%	2,103,045 $292 Million
Q4 2019 Feb 14, 2020	SELL	$106.92 - $132.43 $24.1 Million - $29.8 Million	-225,126 Reduced 9.5%	2,143,875 $282 Million
Q3 2019 Nov 14, 2019	SELL	$106.79 - $116.16 $23.3 Million - $25.4 Million	-218,331 Reduced 8.44%	2,369,001 $265 Million
Q2 2019 Aug 14, 2019	BUY	$110.79 - $129.32 $20.4 Million - $23.9 Million	184,437 Added 7.68%	2,587,332 $287 Million
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $21.8 Million - $25.7 Million	-196,066 Reduced 7.54%	2,402,895 $312 Million
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $50.6 Million - $56.6 Million	477,348 Added 22.5%	2,598,961 $301 Million
Q3 2018 Nov 14, 2018	BUY	$85.86 - $107.31 $4.08 Million - $5.11 Million	47,576 Added 2.29%	2,121,613 $228 Million
Q2 2018 Aug 14, 2018	SELL	$75.7 - $86.88 $261,543 - $300,170	-3,455 Reduced 0.17%	2,074,037 $177 Million
Q1 2018 May 15, 2018	BUY	$74.21 - $87.6 $3.36 Million - $3.96 Million	45,215 Added 2.22%	2,077,492 $161 Million
Q4 2017 Feb 14, 2018	SELL	$81.94 - $87.89 $54.9 Million - $58.9 Million	-670,443 Reduced 24.81%	2,032,277 $172 Million
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $208 Million - $231 Million	2,702,720	2,702,720 $231 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Putnam Investments LLC with notifications on news.

Account

Putnam Investments LLC Eli Lilly & CO Transaction History